Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
The myeloproliferative disorders (MPD) are a domain in which the bone marrow biopsy (BMB) greatly proved its utility. We have studied the histology of the bone marrow (BM) in all the four entities of MPD: chronic myeloid leukemia (CML) with its subtype, chronic megakaryocytic granulocytic myelosis (CMGM), polycythemia vera (PV), hemorrhagic thrombocythemia (HT) and myeloid metaplasia with myelofibrosis (MMM). The work presents in short some of the clinical and hematologic characters of MPD with special stress upon the histologic modifications of BM, either specific or common to all MPD entities, underlying also the criteria for differential diagnosis.
Macavei
I
I
Galatâr
N
N
D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology*; D003937:Diagnosis, Differential; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000473:pathology; D009196:Myeloproliferative Disorders / Q000175:diagnosis / Q000473:pathology*; D011087:Polycythemia Vera / Q000175:diagnosis / Q000473:pathology; D055728:Primary Myelofibrosis / Q000175:diagnosis / Q000473:pathology; D013920:Thrombocythemia, Essential / Q000175:diagnosis / Q000473:pathology